MicroRNA therapeutics: Principles, expectations, and challenges

Chinese Journal of Cancer

Volumn 30, Issue 6, 2011, Pages 368-370

  Rupaimoole, Rajesha ^a   Han, Hee Dong ^a   Lopez Berestein, Gabriel ^a   Sood, Anil K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Chitosan; DOPC; MicroRNA; MiRNA therapeutics; Nanoparticles

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MICRORNA; NANOPARTICLE;

BINDING AFFINITY; BIOGENESIS; EDITORIAL; GENE EXPRESSION REGULATION; HUMAN; IN VIVO GENE TRANSFER; NONHUMAN; RNA BINDING; RNA DEGRADATION;

DRUG DELIVERY SYSTEMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; HUMANS; MICRORNAS; NEOPLASMS; OLIGONUCLEOTIDES, ANTISENSE;

EID: 79959305051     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.30.0368     Document Type: Editorial

References (12)

1. Merritt WM, Lin YG, Han LY, et al. Dicer, Drosha, and outcomes in patients with ovarian cancer [J]. N Engl J Med, 2008,359(25):2641-2650.
2. Lin RJ, Lin YC, Chen J, et al. MicroRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma [J]. Cancer Res, 2010,70(20):7841-7850.
3. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function [J]. Cell, 2004,116(2):281-297.
4. Kim VN. Small RNAs: classification, biogenesis, and function [J]. Mol Cells, 2005,19(1):1-15.
5. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers [J]. Nature, 2005,435(7043):834-838.
6. Martello G, Rosato A, Ferrari F, et al. A microRNA targeting dicer for metastasis control [J]. Cell, 2010,141(7):1195-1207.
7. Krutzfeldt J, Rajewsky N, Braich R, et al. Silencing of microRNAs in vivo with ''antagomirs'' [J]. Nature, 2005,438 (7068):685-689.
8. Chiu YL, Rana TM. SiRNA function in RNAi: a chemical modification analysis [J]. RNA, 2003,9(9):1034-1048.
9. Harborth J, Elbashir SM, Vandenburgh K, et al. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing [J]. Antisense Nucleic Acid Drug Dev, 2003,13 (2): 83-105.
10. Landen CN Jr, Chavez-R eyes A, Bucana C, et al. Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery [J]. Cancer Res, 2005,65 (15):6910-6918.
11. Lu C, Han HD, Mangala LS, et al. Regulation of tumor angiogenesis by EZH2 [J]. Cancer Cell, 2010,18(2):185-197.
12. Shahzad MM, Mangala LS, Han HD, et al. Targeted delivery of small interfering RNA using reconstituted high-de nsity lipoprotein nanoparticles [J]. Neoplasia, 2011,13(4):309-319.